Landmark Privacy Proposal To Give Consumers Control Over Their Genetic Data Advances To Governor Newsom’s Desk For Signature
By George Thomas,
The Government Center Gazette [cites CGS]
| 09. 01. 2020
SACRAMENTO, CA — Senator Thomas J. Umberg (D-Santa Ana) announced today that his measure, Senate Bill 980 (SB 980) passed the California State Assembly and will soon go to the desk of Governor Gavin Newsom to be signed into law. SB 980 would assure consumers that Direct-to-Consumer (DTC) genetic testing companies will use their genetic data solely for the purposes to which they have consented. This bill has support from various privacy and consumer groups, including the American Civil Liberties Union (ACLU), Electronic Frontier Foundation, Consumer Reports, Consumer Action, and Privacy Clearing House, and the Center for Genetics and Society.
“At-home DNA tests have provided people with the ability to seek meaningful connections to long-lost families or their own cultural and religious histories. Most people have no idea that this data can then legally be shared with third parties or potentially used against them in a variety of ways” said Senator Umberg “Genetic testing companies have, to date, gone largely unregulated by either state or national governments. This has led to breaches of sensitive private biological information and a suggestion by even the United...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
